Savant Capital, LLC Amgen Inc Transaction History

Savant Capital, LLC

  • $11.7 Billion
  • Q3 2024

A detailed history of Savant Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Savant Capital, LLC holds 29,368 shares of AMGN stock, worth $7.73 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
29,368
Previous 23,410 25.45%
Holding current value
$7.73 Million
Previous $7.31 Million 29.37%
% of portfolio
0.08%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$309.38 - $337.38 $1.84 Million - $2.01 Million
5,958 Added 25.45%
29,368 $9.46 Million
Q2 2024

Aug 05, 2024
SELL
$262.75 - $319.31 $125,857 - $152,949
-479 Reduced 2.01%
23,410 $7.31 Million
Q1 2024

May 03, 2024
SELL
$268.87 - $324.56 $88,189 - $106,455
-328 Reduced 1.35%
23,889 $6.79 Million
Q4 2023

Feb 05, 2024
SELL
$255.7 - $288.46 $301,470 - $340,094
-1,179 Reduced 4.64%
24,217 $6.97 Million
Q3 2023

Nov 06, 2023
BUY
$218.65 - $271.46 $510,766 - $634,130
2,336 Added 10.13%
25,396 $6.83 Million
Q2 2023

Aug 04, 2023
BUY
$214.27 - $253.37 $1.29 Million - $1.52 Million
6,017 Added 35.3%
23,060 $5.12 Million
Q1 2023

May 02, 2023
SELL
$225.79 - $275.2 $77,897 - $94,944
-345 Reduced 1.98%
17,043 $4.12 Million
Q4 2022

Feb 06, 2023
BUY
$229.03 - $291.01 $145,434 - $184,791
635 Added 3.79%
17,388 $4.57 Million
Q3 2022

Oct 28, 2022
SELL
$224.46 - $253.15 $63,746 - $71,894
-284 Reduced 1.67%
16,753 $3.78 Million
Q2 2022

Jul 22, 2022
BUY
$230.71 - $256.74 $180,184 - $200,513
781 Added 4.8%
17,037 $4.15 Million
Q1 2022

May 05, 2022
SELL
$219.27 - $242.57 $55,913 - $61,855
-255 Reduced 1.54%
16,256 $3.93 Million
Q4 2021

Feb 08, 2022
BUY
$198.88 - $227.6 $1.42 Million - $1.63 Million
7,151 Added 76.4%
16,511 $3.71 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $1.66 Million - $1.94 Million
-7,805 Reduced 45.47%
9,360 $1.99 Million
Q2 2021

Aug 04, 2021
SELL
$233.58 - $259.14 $2.66 Million - $2.95 Million
-11,380 Reduced 39.87%
17,165 $4.18 Million
Q1 2021

May 04, 2021
BUY
$221.91 - $258.6 $4.15 Million - $4.83 Million
18,680 Added 189.36%
28,545 $7.1 Million
Q4 2020

Feb 03, 2021
SELL
$216.38 - $257.67 $103,862 - $123,681
-480 Reduced 4.64%
9,865 $2.27 Million
Q3 2020

Nov 04, 2020
BUY
$234.65 - $260.95 $72,272 - $80,372
308 Added 3.07%
10,345 $2.63 Million
Q2 2020

Aug 11, 2020
SELL
$197.81 - $242.74 $127,587 - $156,567
-645 Reduced 6.04%
10,037 $2.37 Million
Q1 2020

Apr 30, 2020
BUY
$182.24 - $241.7 $970,792 - $1.29 Million
5,327 Added 99.48%
10,682 $2.17 Million
Q4 2019

Jan 31, 2020
SELL
$189.21 - $243.2 $7,000 - $8,998
-37 Reduced 0.69%
5,355 $1.29 Million
Q3 2019

Nov 12, 2019
BUY
$174.11 - $208.62 $32,558 - $39,011
187 Added 3.59%
5,392 $1.04 Million
Q2 2019

Aug 06, 2019
SELL
$166.7 - $195.41 $46,009 - $53,933
-276 Reduced 5.04%
5,205 $959,000
Q1 2019

May 02, 2019
BUY
$180.87 - $203.88 $79,944 - $90,114
442 Added 8.77%
5,481 $1.04 Million
Q4 2018

Feb 05, 2019
SELL
$178.4 - $208.25 $7,492 - $8,746
-42 Reduced 0.83%
5,039 $981,000
Q3 2018

Oct 23, 2018
BUY
$185.29 - $208.89 $24,272 - $27,364
131 Added 2.65%
5,081 $1.05 Million
Q2 2018

Aug 07, 2018
SELL
$166.05 - $186.51 $16,605 - $18,651
-100 Reduced 1.98%
4,950 $914,000
Q1 2018

Apr 27, 2018
BUY
$169.43 - $198.0 $80,479 - $94,050
475 Added 10.38%
5,050 $861,000
Q4 2017

Jan 31, 2018
BUY
$168.79 - $188.59 $22,617 - $25,271
134 Added 3.02%
4,575 $796,000
Q3 2017

Oct 31, 2017
BUY
$167.29 - $191.0 $742,934 - $848,231
4,441
4,441 $828,000

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email